XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY AWARDS (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the nine months ended September 30, 2024 and 2023 follows:

Nine Months Ended September 30, 2024

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

465,680

 

 

$

28.12

 

 

 

5.46

 

 

$

2,782

 

Granted

 

 

59,000

 

 

 

28.86

 

 

 

 

 

 

 

Exercised

 

 

(76,350

)

 

 

22.38

 

 

 

 

 

 

 

Forfeited

 

 

(31,900

)

 

 

32.14

 

 

 

 

 

 

 

Balance, September 30, 2024

 

 

416,430

 

 

$

28.96

 

 

 

5.94

 

 

$

2,380

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

230,390

 

 

$

27.67

 

 

 

4.32

 

 

$

1,591

 

 

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

497,820

 

 

$

28.07

 

 

 

5.87

 

 

$

3,402

 

Granted

 

 

41,500

 

 

 

28.44

 

 

 

 

 

 

 

Exercised

 

 

(21,440

)

 

 

24.05

 

 

 

 

 

 

 

Forfeited

 

 

(48,450

)

 

 

30.62

 

 

 

 

 

 

 

Balance, September 30, 2023

 

 

469,430

 

 

$

28.02

 

 

 

5.53

 

 

$

1,228

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

268,030

 

 

$

25.87

 

 

 

3.96

 

 

$

956

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the nine months ended September 30, 2024 and 2023 follows:

Nine Months Ended September 30, 2024

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

182,570

 

 

$

6.10

 

Granted

 

 

59,000

 

 

 

6.36

 

Vested

 

 

(33,430

)

 

 

5.69

 

Forfeited

 

 

(22,100

)

 

 

9.05

 

Balance, September 30, 2024

 

 

186,040

 

 

$

6.21

 

 

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

216,480

 

 

$

5.95

 

Granted

 

 

41,500

 

 

 

5.82

 

Vested

 

 

(35,860

)

 

 

5.82

 

Forfeited

 

 

(20,720

)

 

 

12.41

 

Balance, September 30, 2023

 

 

201,400

 

 

$

5.95

 

Plan Information

Information related to stock options in the Plan is as follows for the nine months ended:

 

 

September 30, 2024

 

 

September 30, 2023

 

Intrinsic value of options exercised

 

$

916

 

 

$

99

 

Cash received from options exercised

 

 

1,710

 

 

 

516

 

Weighted average fair value of options granted

 

 

6.36

 

 

 

5.82

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the nine months ended September 30, 2024 and 2023 follows:

Nine Months Ended September 30, 2024

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

15,390

 

 

$

28.87

 

Granted

 

 

2,388

 

 

 

30.49

 

Vested

 

 

(4,211

)

 

 

29.28

 

Forfeited

 

 

(400

)

 

 

32.94

 

Balance, September 30, 2024

 

 

13,167

 

 

$

28.90

 

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Nonvested at beginning of year

 

 

18,930

 

 

$

27.51

 

Granted

 

 

2,056

 

 

 

34.10

 

Vested

 

 

(3,670

)

 

 

28.57

 

Forfeited

 

 

(1,076

)

 

 

28.93

 

Balance, September 30, 2023

 

 

16,240

 

 

$

28.02